EnteroMedics Inc.
ETRM
ETRM was delisted on the 20th of October, 2017.
24 hedge funds and large institutions have $457K invested in EnteroMedics Inc. in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 6 closing their positions.
8% less funds holding
Funds holding: 26 → 24 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
58% less capital invested
Capital invested by funds: $1.1M → $457K (-$644K)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $15K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$164K |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$158K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$79.5K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$16.7K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$11.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$46.6K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$42.9K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
-$19K |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$15K |
| 5 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$14K |
ETRM Hedge Fund Activity: Q2 2016 in Review
24 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in EnteroMedics Inc. (ETRM) for Q2 2016, worth a combined $457K — down 58% from $1.1M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ETRM and 4 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 4 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $164K. The largest seller was Wells Fargo, cutting an estimated $46.6K.
- 24 institutional investors held EnteroMedics Inc. (ETRM) as of Q2 2016, down from 26 in Q1 2016.
- Funds reported $457K of EnteroMedics Inc. stock for Q2 2016, down 58% quarter-over-quarter.
- 4 funds opened new EnteroMedics Inc. positions in Q2 2016 and 6 closed out, a net change of -2 holders.
- The largest EnteroMedics Inc. buyer in Q2 2016 was Renaissance Technologies, an estimated $164K added.
- The largest EnteroMedics Inc. seller in Q2 2016 was Wells Fargo, an estimated $46.6K sold.
Based on aggregated 13F filings for Q2 2016.